Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > Europe
Category: All Categories > Life Sciences > Pharmaceuticals > Country Overviews
(103 reports matching your criteria)
1  2    4    
Pharmaceuticals and Healthcare Report - Netherlands Q4 2014
8/27/2014 | published by: BMI Research
... austerity measures to meet the terms of EUbudget criteria and further restrictions on drug expenditure look likely, particularly on essential medicines. Although healthcare expenditure continues to increase (in local currency terms), we maintain our view ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Portugal - Q3 2014
7/23/2014 | published by: BMI Research
... to growth in 2015, while pharmaceuticals will not return to growth until 2019. This isbecause while Portugal exited its bailout programme in May 2014 without the need for a new financialpackage, government austerity measures are ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Spain
7/16/2014 | published by: BMI Research
... to drugmakers operating in the country. Despite calls made by companies for theimplementation of a system that adequately rewards innovation and supports investment in futuremedicines, the government is likely to remain committed to fiscal consolidation ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Moldova
7/16/2014 | published by: BMI Research
... with the EU inJune 2014, which would strengthen the business environment and improve the regulatory structure andaccess to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcaresector with the World ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Greece
7/16/2014 | published by: BMI Research
... will continue to target the pharmaceutical and healthcare industry to reduce public spending.We highlight, however, that the generic drug sector and private healthcare industry will present somegrowth opportunities in the country. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Serbia
7/16/2014 | published by: BMI Research
... reduce itsdebt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feelthe worst of these new measures as they cannot compete on cost compared to larger players in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Slovakia
7/16/2014 | published by: BMI Research
... agencyTASR. The government added that after adding contributions from the state budget, the total funds that havebeen allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The governmentplans to allocate these funds to projects in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Lithuania
7/16/2014 | published by: BMI Research
... The upcoming switch to theeuro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost ofincreasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania withlittle leeway to increase ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Norway Q3 2014
7/11/2014 | published by: BMI Research
... inNorway. In the long term, we believe this will result in stronger downward price pressures on medicinesthat treat long-term chronic medicines, with companies increasingly being required to prove thecost effectiveness of their innovative medicines to ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Ireland Q3 2014
7/2/2014 | published by: BMI Research
... Ireland as one of the highest in Europe. This will have a knock-on effect on government pharmaceutical expenditure, and means that companiesoperating in the country will face ongoing revenue-restricting measures. Meanwhile, we believe the worstof ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Finland Q3 2014
6/25/2014 | published by: BMI Research
... we believe the success of the annual decline in reimbursed medicine prices will result in thegovernment maintaining the generic reference pricing system that is in place. Amplifying price pressures onpatented medicines are the unsystematic price ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United Kingdom Q3 2014
6/25/2014 | published by: BMI Research
... beyond 2014. This drop in spendingreflects the UK government's focus on containing costs within the healthcare sector, and in particularpharmaceutical expenditure. Headline Expenditure Projections Pharmaceuticals: GBP23.32bn (USD36.15bn) in 2013 to GBP22.90bn (USD37.33bn) in 2014;-1.8% in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Switzerland Q3 2014
6/11/2014 | published by: BMI Research
... consumption levels (as a result of an ageing population) and the population's preference for high-value innovative treatments for chronic diseases over lower-value generic medicines. The government operates a generous medicine reimbursement scheme and the country ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... in pharmaceutical spending in Estonia as theEstonian government's policy of fiscal restraint continues. Fiscal tightening has lead to pressure on theEstonian Health Insurance Fund to rein in pharmaceutical expenditure through pricing limits, genericprescribing and reference ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : France Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... deficit reduction target of 3.0% of GDP by 2015 - affectingexpenditure on pharmaceuticals and healthcare as a part of the government's fiscal consolidation plans. However, the new government of Manuel Valls has indicated it may ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Ukraine Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... region. In 2014, owing to the distressed economicsituation in the country, drugmakers can expect a challenging business environment and capital outflowrestrictions. Import taxes, pricing restrictions, and exchange rate volatility present significant risks todrugmakers operating in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: BMI Research
... highly developed pharmaceutical manufacturing industryis increasingly threatened by cheaper suppliers from Eastern Europe and Asia. Even though percapita spending on pharmaceuticals is relatively high, it is subjected to continual downward pressure, whichtranslates into growth opportunities ...  |  read more...
USD 1,295
Pharmaceuticals in Sweden
4/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Sweden pharmaceuticals market. Includes market size data, textual and graphical analysis of ...  |  read more...
USD 350
Pharmaceuticals in Norway
4/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Norway pharmaceuticals market. Includes market size data, textual and graphical analysis of ...  |  read more...
USD 350
Pharmaceuticals in Denmark
4/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Denmark pharmaceuticals market. Includes market size data, textual and graphical analysis of ...  |  read more...
USD 350
Pharmaceuticals in the Czech Republic
4/30/2014 | published by: MarketLine
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Czech Republic pharmaceuticals market. Includes market size data, ...  |  read more...
USD 350
Pharmaceuticals in Belgium
4/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium pharmaceuticals market. Includes market size data, textual and graphical analysis of ...  |  read more...
USD 350
Pharmaceuticals in Hungary
4/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Hungary pharmaceuticals market. Includes market size data, textual and graphical analysis of ...  |  read more...
USD 350
Pharmaceutical And Healthcare Market In Poland 2013
6/1/2013 | published by: PMR
... pharmaceutical and healthcare markets. The experienced analysts at PMR have kept close watch on these changes, observing events and collecting data that documents variations in sales values of various medications, the value of the hospital ...  |  read more...
USD 2,660
Intellinews - Polish Pharmaceutical Sector Report - October 2012
11/2/2012 | published by: Intellinews
... comments. This sector report is ideal to keep you abreast on recent company and industry news. Written by local professionals, it is a unique market and business intelligence analysis, tailored to save time by providing ...  |  read more...
USD 240
1  2    4